Perceptions of Patients and Medical Oncologists Toward Biospecimen Donation in the Setting of Abnormal Breast Imaging Findings.
Sacred Heart Health Service,Tayob Nabihah,Leone Jose Pablo,Hu Jiani,Yin Jun,Hughes Melissa,Montana Cancer Center,Lederman Ruth I.,Frank Elizabeth,Squannacook Early Childhood Center,Stadler Zsofia K.,Erick Timothy K.,Peppercorn Jeffrey,Winer Eric P.,Silverman Stuart G.,Come Steven E.,Lin Nancy U.
DOI: https://doi.org/10.1007/s10549-021-06494-z
2022-01-01
Breast Cancer Research and Treatment
Abstract:PURPOSE:We sought to understand the attitudes of individuals with abnormal breast imaging findings prompting a diagnostic breast biopsy toward donation of blood, excised tissue, or percutaneous biospecimens for research, and to understand medical oncologists' attitudes toward research biospecimen collection in this population.METHODS:We included individuals who presented to a single academic medical center for a clinically indicated, image-guided, percutaneous breast biopsy. We administered a survey prior to knowledge of biopsy results to assess willingness to consider, entirely for research purposes, donating blood or excess excised breast tissue, or having additional biospecimens (AB) obtained during a clinically indicated percutaneous biopsy. We also surveyed breast medical oncologists from National Cancer Institute-designated cancer centers to assess attitudes toward approaching patients for biospecimen research.RESULTS:Overall, 53/63 patients responded to the survey; 70% would consider donating blood, 85% would consider donating excess excised breast tissue, and 32% would consider having AB obtained during a clinically indicated biopsy. Main motivating factors for considering AB included contributing to scientific knowledge and return of study or biopsy results, whereas anxiety and the potential discomfort were the main dissuading factors. Among 191 medical oncologists, most were very comfortable (59.2%), or somewhat comfortable (32.5%) asking patients to have AB obtained during a clinically indicated breast biopsy. Medical oncologists reported hesitancy to refer a patient for AB due to potential pain/discomfort, and other procedure risks.CONCLUSIONS:Only one-third of individuals with breast imaging findings would consider consenting to AB during a diagnostic biopsy, whereas most were open to donating blood or excess excised breast tissue. Most medical oncologists would be comfortable asking patients to have AB obtained during the biopsy. Understanding patients' and oncologists' baseline attitudes may inform the design and approach to breast biospecimen-based research.